Explore active and passive temperature-controlled shipping solutions and their impact on clinical trial supply, balancing cost, risk, and product integrity.
- Leveraging Conventional Therapeutics Skills For Cell And Gene Therapy
- Why Clinical Supply Risk Starts With Demand Signals
- A Year Of Separation: Which Advanced Modalities Are Built For Commercial Scale In 2026?
- New ISPE Framework Targets Uncertainty In Pharma's AI Deployment
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- In Vivo's Biggest Threat — Comparison To Old Models
- The 5-Layer Fix For AI Failure In Pharmaceutical Manufacturing
- Why Use Total Organic Carbon Analysis For Cleaning Validation?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Emergent BioSolutions]( "Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer")
Aseptic Filling Solution Enhances Sterility Assurance for Pharma ManufacturerEmergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.
-
![BioPhorum]( "Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration")
Handle Single-Use Technology Biopharma Waste: Data Sharing, CollaborationLearn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.
-
![GettyImages-1491009758 lab, cell culture]( "A Non-Viral Workflow For Modifying Primary T Cells")
A Non-Viral Workflow For Modifying Primary T CellsThis study demonstrates the ability of combined platforms with complimentary technologies to modify primary T cells in a functionally-closed, automated fashion.
-
![Entegris - mixing]( "Mixing Of Various Dry Powdered Media And Buffers")
Mixing Of Various Dry Powdered Media And BuffersExplore how this mixing system efficiently handles various powdered media and buffers, ensuring precise solubilization and mixing in applications like cell culture and protein purification.
-
![GettyImages-1935725164-disease-cell-blue]( "3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived Neurons")
3D Neurospheres In Healthy And Alzheimer's: iPSC-Derived NeuronsExplore how different ApoE alleles influence Alzheimer's Disease risk using iPSC-derived neurons as well as gain insights into AD mechanisms and potential therapies.
-
![GettyImages-1793747580-DNA-double-helix-AI]( "Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer")
Digital Biomanufacturing, Now: From Digital Dreamer To Digital DoerDiscover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
![GettyImages-1220382102-lab-research]( "Expansion Of Human Umbilical Cord-Derived MSCs")
Expansion Of Human Umbilical Cord-Derived MSCsDiscover how high-quality, multipotent stromal cells are efficiently produced for regenerative medicine. Learn about their impressive viability and critical marker expression for therapeutic uses.
-
![GettyImages-1337678825-assay-well-plate-cell-culture]( "Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids")
Matrigel Dome Assay And Drug Screening Of Colorectal Cancer OrganoidsUsing CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.
-
![GettyImages-1746637448-laboratory-tablet-analysis-vial]( "Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA")
Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNADiscover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.
-
![GettyImages-2036497686-lab-team-collaboration-laboratory-tablet-computer]( "Standardize Flow Cytometry Data With Easy Assay Transfer Across Sites")
Standardize Flow Cytometry Data With Easy Assay Transfer Across SitesGain insight into how a global pharmaceutical company successfully transferred their cell therapy assays across international locations.
NEWSLETTER ARCHIVE
- 02.13.26 -- Strengthening Your Regulatory Path: Strategies For Compliance And Safety
- 02.13.26 -- Developing Itvisma For Broad-Range Treatment Of SMA With Dr. Norman Putzki
- 02.12.26 -- Why Your MVP And Its Evolution Matters To Manufacturing
- 02.11.26 -- Breakthroughs In Cell Research & Automation
- 02.11.26 -- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- Disciplined CGT Will Win On 2026 Regulatory Flexibility
- ARM's Tim Hunt On Expanding Patient Access, Smarter Regulation, And A More Sustainable Market In 2026
- Global Shifts And Strategic Resilience Will Shape CGT In 2026
- Why Efficiency In Multi-Modal CGT Manufacturing Is About Execution, Not Just Cost
- CSL's HEMGENIX Shows Durable Benefit, A New Future For Gene Therapy in Hemophilia B
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
